Roope Männikkö

ORCID: 0000-0002-8727-9184
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ion channel regulation and function
  • Cardiac electrophysiology and arrhythmias
  • Genetic Neurodegenerative Diseases
  • Cardiomyopathy and Myosin Studies
  • Neuroscience and Neural Engineering
  • Neuroscience and Neuropharmacology Research
  • Pancreatic function and diabetes
  • Cardiac Ischemia and Reperfusion
  • Muscle Physiology and Disorders
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Myasthenia Gravis and Thymoma
  • Genomics and Rare Diseases
  • Neuroscience of respiration and sleep
  • Amyotrophic Lateral Sclerosis Research
  • Receptor Mechanisms and Signaling
  • Neurogenetic and Muscular Disorders Research
  • Ion Transport and Channel Regulation
  • Neurological disorders and treatments
  • Nicotinic Acetylcholine Receptors Study
  • Glycogen Storage Diseases and Myoclonus
  • Heart Failure Treatment and Management
  • Signaling Pathways in Disease
  • Thyroid and Parathyroid Surgery
  • Ion Channels and Receptors
  • RNA Research and Splicing

National Hospital for Neurology and Neurosurgery
2016-2025

University College London
2015-2024

MRC Prion Unit
2014-2019

Tampere University
2017-2019

University of California, Los Angeles
2019

Vaasa Central Hospital
2017-2019

University of Helsinki
2017

University of Oxford
2009-2016

Centre National de la Recherche Scientifique
2015

Université Laval
2015

Vincenzo Salpietro Christine L. Dixon Hui Guo Oscar D. Bello Jana Vandrovcová and 95 more Stéphanie Efthymiou Reza Maroofian Gali Heimer Lydie Bürglen Stéphanie Valence Erin Torti Moritz Hacke Julia Rankin Huma Tariq Estelle Colin Vincent Procaccio Pasquale Striano Kshitij Mankad Andreas Lieb Sharon Chen Laura Rosa Pisani Conceição Bettencourt Roope Männikkö Andreea Manole Alfredo Brusco Enrico Grosso Giovanni Battista Ferrero Judith Armstrong-Moron Sophie Guéden Omer Bar‐Yosef Michal Tzadok Kristin G. Monaghan Teresa Santiago‐Sim Richard Person Megan T. Cho Rebecca Willaert Yongjin Yoo Jong‐Hee Chae Yingting Quan Huidan Wu Tianyun Wang Raphael Bernier Kun Xia Alyssa Blesson Mahim Jain Mohammad Mahdi Motazacker Bregje Jaeger Amy L. Schneider Katja Boysen Alison M. Muir Candace T. Myers Ralitza H. Gavrilova Lauren Gunderson Laura Schultz‐Rogers Eric W. Klee David A. Dyment Matthew Osmond Mara Parellada Cloe Llorente Javier González‐Peñas Ángel Carracedo Arie van Haeringen Claudia Ruivenkamp Caroline Nava Delphine Héron Rosaria Nardello Michele Iacomino Carlo Minetti Aldo Skabar Antonella Fabretto Michael G. Hanna Enrico Bugiardini Isabel C. Hostettler Benjamin O’Callaghan Alaa Khan Andrea Cortese Emer O’Connor Wai Y. Yau Thomas Bourinaris Rauan Kaiyrzhanov Viorica Chelban M Madej Maria C. Diana Maria S. Vari Marina Pedemonte Claudio Bruno Ganna Balagura Marcello Scala Chiara Fiorillo Lino Nobili Nancy T. Malintan M. Natalia Zanetti Shyam S. Krishnakumar Gabriele Lignani James E.C. Jepson Paolo Broda Sımona Baldassari Pia Rossi Floriana Fruscione Francesca Madia

Abstract AMPA receptors (AMPARs) are tetrameric ligand-gated channels made up of combinations GluA1-4 subunits encoded by GRIA1-4 genes. GluA2 has an especially important role because, following post-transcriptional editing at the Q607 site, it renders heteromultimeric AMPARs Ca 2+ -impermeable, with a linear relationship between current and trans-membrane voltage. Here, we report heterozygous de novo GRIA2 mutations in 28 unrelated patients intellectual disability (ID) neurodevelopmental...

10.1038/s41467-019-10910-w article EN cc-by Nature Communications 2019-07-12

See Cannon (doi: 10.1093/brain/awv400 ) for a scientific commentary on this article. Congenital myopathies are clinically and genetically heterogeneous group of muscle disorders characterized by congenital or early-onset hypotonia weakness, specific pathological features biopsy. The phenotype ranges from foetal akinesia resulting in utero neonatal mortality, to milder that not life-limiting. Over the past decade, more than 20 new myopathy genes have been identified. Most encode proteins...

10.1093/brain/awv352 article EN cc-by-nc Brain 2015-12-22

Hyperpolarization-activated, cyclic nucleotide-gated (HCN) ion channels are important for rhythmic activity in the brain and heart. In this study, using ionic gating current measurements, we show that cloned spHCN undergo a hysteresis their voltage dependence during normal gating. For example, both charge versus curve, Q(V), conductance G(V), shifted by about +60 mV when measured from hyperpolarized holding potential compared with depolarized potential. addition, kinetics of tail activation...

10.1085/jgp.200409130 article EN The Journal of General Physiology 2005-02-14

Gain-of-function mutations in Kir6.2 (KCNJ11), the pore-forming subunit of adenosine triphosphate (ATP)-sensitive potassium (KATP) channel, cause neonatal diabetes. Many patients also suffer from hypotonia (weak and flaccid muscles) balance problems. The diabetes arises suppressed insulin secretion by overactive KATP channels pancreatic beta-cells, but source motor phenotype is unknown. By using mice carrying a human mutation (Val59-->Met59) targeted to either muscle or nerve, we show that...

10.1126/science.1186146 article EN Science 2010-07-02

The finding that patients with diabetes due to potassium channel mutations can transfer from insulin sulfonylureas has revolutionised the management of permanent neonatal diabetes. extent which in vitro characteristics mutation predict a successful is not known. Our aim was identify factors associated KCNJ11 (which encodes inwardly rectifying Kir6.2). We retrospectively analysed clinical data on 127 who attempted sulfonylureas. considered when completely discontinued whilst All unsuccessful...

10.1007/s00125-016-3921-8 article EN cc-by Diabetologia 2016-03-31

BackgroundSudden infant death syndrome (SIDS) is the leading cause of post-neonatal in high-income countries. Central respiratory system dysfunction seems to contribute these deaths. Excitation that drives contraction skeletal muscles controlled by sodium channel NaV1.4, which encoded gene SCN4A. Variants NaV1.4 directly alter muscle excitability can myotonia, periodic paralysis, congenital myopathy, and myasthenic syndrome. SCN4A variants have also been found infants with life-threatening...

10.1016/s0140-6736(18)30021-7 article EN cc-by The Lancet 2018-04-01

<h3>Objective:</h3> To determine the molecular basis of a complex phenotype congenital muscle weakness observed in an isolated but consanguineous patient. <h3>Methods:</h3> The proband was evaluated clinically and neurophysiologically over period 15 years. Genetic testing candidate genes performed. Functional characterization mutation done mammalian cell background using whole patch clamp technique. <h3>Results:</h3> had fatigable characteristic myasthenic syndrome with acute reversible...

10.1212/wnl.0000000000002264 article EN Neurology 2015-12-12

Voltage-gated ion channels respond to changes in the transmembrane voltage by opening or closing their conducting pore. The positively charged fourth segment (S4) has been identified as main sensor, but mechanisms of coupling between sensor and gates are still unknown. Obtaining information about location exact motion S4 is an important step toward understanding these mechanisms. In previous studies we have shown that extracellular end located close 5 (S5). purpose present study estimate...

10.1085/jgp.118.1.1 article EN The Journal of General Physiology 2001-07-01

Hyperpolarization-activated, cyclic-nucleotide-gated (HCN) channels regulate pacemaker activity in the heart and brain. Previously, we showed that spHCN HCN1 undergo mode shifts their voltage dependences, shifting conductance versus curves by more than +50 mV when measured from a hyperpolarized potential compared to depolarized potential. In addition, kinetics of ionic currents changed parallel these shifts. studies reported here, tested whether slower cardiac HCN also display similar We...

10.1113/jphysiol.2006.110437 article EN The Journal of Physiology 2006-06-16

The X-ray crystallographic structure of KvAP, a voltage-gated bacterial K channel, was recently published. However, the position and molecular movement voltage sensor, S4, are still controversial. For example, in structure, S4 is located far away (&amp;gt;30 Å) from pore domain, whereas electrostatic experiments have suggested that close (&amp;lt;8 to domain open channels. To test proposed location motion relative we induced disulphide bonds between pairs introduced cysteines: one domain....

10.1085/jgp.200308927 article EN The Journal of General Physiology 2003-11-10

Research Article12 June 2009Open Access Adjacent mutations in the gating loop of Kir6.2 produce neonatal diabetes and hyperinsulinism Kenju Shimomura Henry Wellcome Centre for Gene Function, Department Physiology, Anatomy Genetics, University Oxford, UK Search more papers by this author Sarah E. Flanagan Institute Biomedical Clinical Research, Peninsula Medical School, Exeter, Brittany Zadek Mark Lethby Lejla Zubcevic Christophe A. J. Girard Oliver Petz St. Vincenz Hospital Coesfeld,...

10.1002/emmm.200900018 article EN cc-by EMBO Molecular Medicine 2009-06-01

Hypokalaemic periodic paralysis is a rare genetic neuromuscular disease characterized by episodes of skeletal muscle associated with low serum potassium. Muscle fibre inexcitability during attacks due to an aberrant depolarizing leak current through mutant voltage sensing domains either the sarcolemmal voltage-gated calcium or sodium channel. We report child hypokalaemic and CNS involvement, including seizures, but without mutations in known genes. identified novel heterozygous de novo...

10.1093/brain/awy283 article EN cc-by Brain 2018-10-15

To identify the genetic and physiologic basis for recessive myasthenic congenital myopathy in 2 families, suggestive of a channelopathy involving sodium channel gene, SCN4A. A combination whole exome sequencing targeted mutation analysis, followed by voltage-clamp studies mutant channels expressed fibroblasts (HEK cells) Xenopus oocytes. Missense mutations same residue skeletal muscle channel, R1460 NaV1.4, were identified family single patient Finnish origin (p.R1460Q) proband United States...

10.1212/wnl.0000000000007185 article EN cc-by Neurology 2019-03-02

Abstract High-throughput DNA sequencing is increasingly employed to diagnose single gene neurological and neuromuscular disorders. Large volumes of data present new challenges in interpretation its useful translation into clinical genetic counselling for families. Even when a plausible identified with confidence, the significance inheritance pattern variants can be challenging. We report our approach evaluating skeletal muscle chloride channel ClC-1 223 probands myotonia congenita as an...

10.1093/brain/awab344 article EN cc-by Brain 2021-09-13

ABSTRACT Background This study aimed to determine the role of five new rare SCN4A variants suspected cause paramyotonia or myotonic disorder. Methods Ten patients from seven families underwent clinical, neurophysiological, imaging, and muscle biopsy examinations. Genetic studies were performed with targeted sequencing all known myopathy genes. Functional changes resulting these studied HEK293T cells, by using a whole‐cell patch clamp. Results Five identified: c.662 T &gt; C p.(F221S),...

10.1111/ene.70157 article EN cc-by-nc European Journal of Neurology 2025-05-01

Potencies of compounds blocking K(V)11.1 [human ether-ago-go-related gene (hERG)] are commonly assessed using cell lines expressing the Caucasian wild-type (WT) variant. Here we tested whether such potencies would be different for hERG single nucleotide polymorphisms (SNPs).SNPs (R176W, R181Q, Del187-189, P347S, K897T, A915V, P917L, R1047L, A1116V) and a binding-site mutant (Y652A) were expressed in Tet-On CHO-K1 cells. [mean IC(50); lower/upper 95% confidence limit (CL)] 48 blockers was...

10.1111/j.1476-5381.2009.00334.x article EN British Journal of Pharmacology 2009-08-10

Significance Voltage-gated ion channels contain domains that have discrete functionalities. The central pore domain allows current flow and provides selectivity, whereas peripherally located voltage-sensing (VSDs) are needed for voltage-dependent gating. Certain mutations trigger a leak through VSDs, known as gating current. Hypokalemic periodic paralysis (HypoPP) type 2 is caused by in the skeletal muscle voltage-gated sodium channel Na V 1.4 neutralize positive charges S4 segments of VSDs....

10.1073/pnas.1720185115 article EN cc-by-nc-nd Proceedings of the National Academy of Sciences 2018-04-10

Mutations in the skeletal muscle channel (SCN4A), encoding Nav1.4 voltage-gated sodium channel, are causative of a variety channelopathies, including non-dystrophic myotonias and periodic paralysis. The effects many these mutations on function have been characterized both vitro vivo. However, little is known about consequences SCN4A downstream from their impact electrophysiology channel. Here we report discovery novel mutation (c.1762A>G; p.I588V) patient with myotonia paralysis, located...

10.1093/brain/awu292 article EN cc-by Brain 2014-10-20

OBJECTIVE Two novel mutations (E1506D, E1506G) in the nucleotide-binding domain 2 (NBD2) of ATP-sensitive K+ channel (KATP channel) sulfonylurea receptor 1 (SUR1) subunit were detected heterozygously patients with neonatal diabetes. A mutation at same residue (E1506K) was previously shown to cause congenital hyperinsulinemia. We sought understand why can either diabetes or RESEARCH DESIGN AND METHODS Neonatal diabetic sequenced for ABCC8 and KCNJ11 (Kir6.2). Wild-type mutant KATP channels...

10.2337/db10-1583 article EN cc-by-nc-nd Diabetes 2011-05-21

Abstract Dominantly inherited channelopathies of the skeletal muscle voltage-gated sodium channel Na V 1.4 include hypokalaemic and hyperkalaemic periodic paralysis (hypoPP hyperPP) myotonia. HyperPP myotonia are caused by overactivity overlap clinically. Instead, hypoPP is gating pore currents through voltage sensing domains (VSDs) seldom co-exists clinically with Recessive loss-of-function mutations have been described in congenital myopathy myasthenic syndromes. We report two families...

10.1038/s41598-018-27822-2 article EN cc-by Scientific Reports 2018-06-20
Coming Soon ...